Position in GHRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,403,618
+$1,040,450 QoQ
Shares Held
52,218
+102.2% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 62 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. GHRS ranks #233 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in GHRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,403,618 | 52,218 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $363,168 | 25,830 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $652,830 | 51,404 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $60,659 | 4,242 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,425,412 | 281,002 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,058,076 | 277,251 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,858,276 | 265,468 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,730,167 | 258,620 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,404,078 | 291,945 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $2,998,807 | 281,314 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,868,934 | 322,230 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $3,087,448 | 307,209 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $4,671,700 | 393,738 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,130,919 | 391,855 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,094,396 | 524,115 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,686,083 | 489,336 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,776,617 | 478,619 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $7,708,283 | 421,448 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $10,369,275 | 444,461 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,359,175 | 424,260 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,383,549 | 201,728 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||